Preview

User

Not a user? Register with this site Forgot your password?

Problems of Endocrinology

Advanced search

Evaluation of the efficacy of gonadotrophic inductors of ovulation in rats with hyperandrogenemia given flutamide

https://doi.org/10.14341/probl201157428-31

Abstract

The objective of the present work was to study the influence of antiandrogen flutamide (flutapharm) at a dose of 1.0 mg/kg b.w., human chorionic gonadotropin (choragon, 5 IU), and folliculostimulating hormone (menopur, 0.01 IU) on the morphofunctional characteristics of ovaries. These products were administered either alone or sequentially to sexually mature female rats after the implantation of testosterone-containing polymeric capsules. The presence of hyperandogenism was confirmed by the five-fold rise in the blood testosterone levels. Analysis of the oestrus cycle, the weight and histological structure of the ovaries gave evidence of disturbed folliculogensis, degenerative changes in follicular epithelium, the development of ovarian polycystosis and anovulatory state in the hyperandrogenic animals. It is concluded neither flutamide nor gonadotrophic hormones administered at the above doses promoted normalization of the generative function of rat ovaries. At the same time, stimulation with gonadotropins following glutamide administration restored folliculogenesis, ovulation, an formation of luteal bodies. The results of this study indicate that flutamide can be used to enhance the stimulating action of gonadotropic hormones on the ovaries in hyperandrogenic individuals.

References

1. Чернуха Г.Е. Современные представления о синдроме поликистозных яичников. Гинекологическая эндокринология 2002; 4: 8: 24-27.

2. Homburg R. Ovulation induction. Expert Opin Pharmacother 2003; 4: 11: 1995-2004.

3. Yarali H., Zeyneloglu H.B. Gonadotrophin treatment in patients with polycystic ovary syndrome. Reprod Biomed Online 2004; 8: 5: 528-537.

4. Szilagyi A., Bartfai G., Manfai A. et al. Low-dose ovulation induction with urinary gonadotropins or recombinant follicle-stimulating hormone in patients with polycystic ovary syndrome. Gynecol Endocrinol 2004; 18: 1: 17-22.

5. Тарасенко Л.В., Носенко Н.Д., Синицын П.В., Резников А.Г. Экспериментальная терапия нарушений половой цикличности у крыс с гиперандрогенией. Клин эксперим патология 2004; 3: 2: 140-142 (Укр.).

6. Татарчук Т.Ф., Ганжий И.Ю., Березовская Е.Т., Шевчук Т.В. Лечение гиперандрогении как причины нарушения репродуктивного здоров'я женщины. Здоровье женщины 2009; 42: 6: 147-151.

7. Голота В.Я., Усевич И.А., Тарасенко Л.В., Борис Е.Н. Применение Флутафарма для лечения гиперандрогении при синдроме склерополикистозных яичников. Репродуктивное здоровье женщины 2008; 37: 3: 139-142 (Укр.).

8. Резников А.Г., Синицын П.В., Тарасенко Л.В., Полякова Л.И. Нейроэндокринные механизмы развития экспериментальной ановуляции гиперандрогенного происхождения. Пробл эндокринол 2002; 48: 6: 50-53.

9. Armstrong D.T., Parkoff H. Stimulation of aromatization of exogenous and endogenous androgens in ovaries of hypophysectomized rats in vivo by follicle-stimulating hormone. Endocrinology 1976; 99: 1144-1151.


Review

For citations:

Reznikov A.G., Nosenko N.D., Boris E.N., Poliakova L.I., Sinitsyn P.V., Tarasenko L.V. Evaluation of the efficacy of gonadotrophic inductors of ovulation in rats with hyperandrogenemia given flutamide. Problems of Endocrinology. 2011;57(4):28-31. https://doi.org/10.14341/probl201157428-31

Views: 430


ISSN 0375-9660 (Print)
ISSN 2308-1430 (Online)

11, Dm. Ul’yanova str., Moscow, Russian Federation, 117292

Processing of personal data
supported by NEICON (Elpub lab)